Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

The MPV/PC ratio can help assess disease activity in alopecia areata.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Promising cancer treatments were found, but the manufacturer closed.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Baicalin may help treat severe drug-induced skin reactions.

Certain blood cell ratios are higher in kids with alopecia areata and might help predict the disease.

Activating autophagy might reverse skin fibrosis.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Bimekizumab quickly improves psoriasis symptoms and skin at the molecular level.

Lighter skin types respond better to narrowband UVB therapy for cutaneous T-cell lymphoma than darker skin types.

BAP1 mutations are rare in pediatric melanocytic tumors and may develop later in life.

BMAL1 controls skin cell growth and UV damage risk, peaking at night.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Using both bone marrow concentrate and platelet-rich plasma together improves skin wound healing in mice.

Certain proteins and cytokines are key in causing psoriatic skin issues.